pharma news today glp-1 obesity drugs october 2025 trends 2025: real-world data, patient outcomes & future therapies Pharma Giants Bet on Next-Generation – GLP-1 Pharma Marketing Strategy for

In recent years, the treatment landscape for obesity has evolved rapidly, with GLP-1 (glucagon-like peptide-1) agonists emerging as a powerful tool in weight management

Studies suggest that AOXs, such as CoQ10, vitamins C and E, melatonin, NAC, and alpha-lipoic acid (ALA), may improve oocyte quality, enhance endometrial receptivity, and restore hormonal balance by mitigating OS (188, 189)

Boehringer Ingelheim agreed to pay Yuhan $40 million upfront, of which $10 million will come after a preclinical toxicity test

Lipo-C Regulatory Status As of July 2026 , Lipo-C is not FDA-approved

Provides a radiant, flawless complexion Reduces pigmentation and evens skin tone Improves skin texture and brightness Perfect for special occasions or a rejuvenating glow 8